ESTUDIO SUSTANCIAS ANTAGONISTAS PRODUCIDAS POR MICROORGANISMOS
ESTUDIO SUSTANCIAS ANTAGONISTA
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milán, ItaliaPublications in collaboration with researchers from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (7)
2024
-
Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants
npj Genomic Medicine, Vol. 9, Núm. 1
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Journal of Clinical Investigation, Vol. 131, Núm. 23
-
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085
-
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
Scientific Reports, Vol. 11, Núm. 1
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477